HDAC2 and mature T-cell and NK-cell non-Hodgkin lymphoma: In peripheral T-cell lymphoma (PTCL), HDAC2 was detected to be overexpressed and considered to be a prognostic marker, particularly for patients with the PTCL-NOS subtype [126].